Endocrine Delivery System of NK4, an HGF-Antagonist and Anti-Angiogenic Regulator, for Inhibitions of Tumor Growth, Invasion and Metastasis

doi 10.5772/26485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Interruption of the HGF Paracrine Loop by NK4, an HGF Antagonist, Reduces VEGF Expression of CT26 Cells

Oncology Reports
MedicineCancer ResearchOncology
2013English

Inhibition of Lymph Node Metastasis by an Anti-Angiogenic Agent, TNP-470

British Journal of Cancer
Cancer ResearchOncology
1997English

An Anti-Cd133 Monoclonal Antibody CMab-43 Exerts Anti-Tumor and Anti-Metastasis Activities for Colon Cancers

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

669. A Tumor Targeting Delivery System for Realizing siRNA as an Anti-Cancer Nanomedicine

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Anti-Tumor Effects of an Id Antagonist With No Acquired Resistance

2020English

Thymidine Phosphorylase Is Angiogenic and Promotes Tumor Growth.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment

Cancer Growth and Metastasis
2014English

High Gene Expression of Semaphorin 5A in Pancreatic Cancer Is Associated With Tumor Growth, Invasion and Metastasis

International Journal of Cancer
Cancer ResearchOncology
2010English

MYB Is a Novel Regulator of Pancreatic Tumour Growth and Metastasis

British Journal of Cancer
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy